Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Thyrocare Technologies Limited Regulatory Filings 2020

Mar 7, 2020

61766_rns_2020-03-07_549a3cb3-89ca-44b2-aa8f-9ddf6ef68c6f.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [42 x 85] intentionally omitted <==

ocare Thyr

Think Thyroid. Think Thyrocare.

March 07, 2020

The National Stock Exchange oflndia Limited The Bombay Stock Exchange Ltd Exchange Plaza Phiroze Jeejeeboy Towers Sandra Kurla Complex, Dalal Street, Sandra (E), Mumbai - 400 051 Mumbai- 400 00 I

==> picture [10 x 48] intentionally omitted <==

Dear Sir/Madam,

Sub: Disclosure of information under Regulation 30 of SEBI (Listing Obligations and Disclosure - Requirements) Regulations, 2015 Meeting with Investor/Analyst

--0--

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you about the following forthcoming Analyst Meetings to be held at the Corporate Office of the Company:

  • i) Meeting with the representative(s) of J. P. Morgan India Private Limited, at 11.30 A.M. on Wednesday, March 11, 2020.

  • ii) Meeting with the representative(s) of Aditya Birla Capital, at 11.00 A.M. on Thursday, March 12, 2020.

iii) Meeting with the representative(s) of Hill Fort Capital Partners Limited, at 11.30 A.M. on Wednesday, March 18, 2020.

Please note that these meetings are subject to any last minute changes.

Yours Faithfully,

For Thyrocare Technologies Limited,

==> picture [41 x 22] intentionally omitted <==

Ramjee Dorai Company Secretary and Compliance Officer

==> picture [82 x 85] intentionally omitted <==

Thyrocare Technologres Lrm,ted

9 D 37/1, TTC MIDC, Turbhe, Navi Mumbai - 400 703, India (9 022- 3090 0000 / 4125 2525 .:-. [email protected] ((I}) www.thyrocare.com